Lv3
380 积分 2023-07-10 加入
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial
2个月前
已关闭
Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
Predicting lifetime risk for developing atherosclerotic cardiovascular disease in Chinese population: the China-PAR project
7个月前
已完结
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
8个月前
已关闭
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
1年前
已关闭
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
1年前
已完结
Per-Particle Cardiovascular Risk of Lipoprotein(a) vs Non-Lp(a) Apolipoprotein B-Containing Lipoproteins
1年前
已完结
Lipoprotein(a) Is Markedly More Atherogenic Than LDL
1年前
已完结
Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure
1年前
已关闭
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
1年前
已完结
皖公网安备34019202002308
